| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/06/2005 | WO2005000883A1 Polypeptides having binding affinity for insulin |
| 01/06/2005 | WO2005000875A2 Compositions and methods comprising a ligand of chemerin receptor |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000351A2 Combination therapy for b cell disorders |
| 01/06/2005 | WO2005000350A1 Medication and method for treating pathological syndrome |
| 01/06/2005 | WO2005000349A2 Passive immune therapy against malignant melanoma |
| 01/06/2005 | WO2005000227A2 Methods of treating tnf-mediated disorders |
| 01/06/2005 | WO2005000225A2 Production of rabies antibodies in plants |
| 01/06/2005 | WO2005000223A2 Method of treating retinopathies and disorders associated with blood vessel loss |
| 01/06/2005 | WO2005000207A2 Pcdgf receptor antibodies and methods of use thereof |
| 01/06/2005 | WO2005000194A2 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same |
| 01/06/2005 | WO2004087756A3 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/06/2005 | WO2004085478A3 Improved fc fusion proteins |
| 01/06/2005 | WO2004075813A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii) |
| 01/06/2005 | WO2004072117A3 Antibodies to c-met for the treatment of cancers |
| 01/06/2005 | WO2004062684A3 Treatment of thrombocytopenia with inhibitors of pacap |
| 01/06/2005 | WO2004058167A3 Breast specific protein expressed in cancer and methods of use thereof |
| 01/06/2005 | WO2004051280A3 Identification of agonistic autoantibodies |
| 01/06/2005 | WO2004047863A3 Genetic products differentially expressed in tumors and the use thereof |
| 01/06/2005 | WO2004041997A3 Immunotherapy regimens in hiv-infected patients |
| 01/06/2005 | WO2003097688A9 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2002055700A8 Human genes and gene expression products isolated from human prostate |
| 01/06/2005 | US20050005310 Expression vectors and methods |
| 01/06/2005 | US20050004355 Diagnosing immune system disorders using defensin specific immuoglobulin; microbiocides and treatment of respiratory system disorders |
| 01/06/2005 | US20050004354 Human antibodies that bind human IL-12 and methods for producing |
| 01/06/2005 | US20050004353 Immunoglobulin for use in treatment and prevention of viral infection, glandular, inflammatory, nervous system, blood, skin, cardiovascular and liver disorders; immunotherapy |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004349 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/06/2005 | US20050004346 Recombinant anti-plasmodium falciparum antibodies |
| 01/06/2005 | US20050004066 Monoclonal antibodies specific to VEGF receptors and uses thereof |
| 01/06/2005 | US20050004054 Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004027 Administering a compound which blocks endothelial growth factor |
| 01/06/2005 | US20050004015 Novel haemopoietin receptor and genetic sequences encoding same |
| 01/06/2005 | US20050004008 Determining metastatic of cancer using concentration of phosphorylated adaptor protein; anticancer agenst |
| 01/06/2005 | US20050004003 Substance which inhibits binding of information transfer molecule for 1175-tyrosine phosphorylated KDR/Flk-1 and usages of the same |
| 01/06/2005 | US20050003998 Therapeutic use of selective LXR modulators |
| 01/06/2005 | US20050003560 Apparatus comprising immobilied antibodies for use in detection of preferential compounds in solution; biosensor |
| 01/06/2005 | US20050003548 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003493 Kit comprising immunoblobulins which bind the bioactive, three-dimensional epitope of parathyroid hormone for use in classifying hypercalcemic disorders |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |
| 01/06/2005 | US20050003482 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 01/06/2005 | US20050003477 Expression vector comprising nucleotide sequences coding brain cyclic nucleotide gated ion channel (BCNG) protein for use in treatment and prevention of nervous system, urogenital and cardiovascular disorders |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003469 Immunoglobulin specific to abnormally proliferating cells for use in prevention and treatment of cancer disorders; immunotherapy; immunodiagnostics |
| 01/06/2005 | US20050003466 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 01/06/2005 | US20050003465 Monoclonal abtibody specific to prostate cell-surface antigen associated with androgen-dependent and androgen-independent prostate tumors for use in prevention, diagnosis and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 01/06/2005 | US20050003461 Determining allergenic sensitivity via monitoring concentration of mast and/or basophil cells in blood after exposure to interleukins; immunoassays |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003450 Immunoaffinity isolation of modified peptides from complex mixtures |
| 01/06/2005 | US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders |
| 01/06/2005 | US20050003445 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003431 Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor |
| 01/06/2005 | US20050003425 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 01/06/2005 | US20050003422 Determining response to administration of farnesyl transferase inhibitor such as (R)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone) by analyzing the presence or expression of oncogene; kits |
| 01/06/2005 | US20050003413 Using single chain immunoglobulin fragments as epitope anchors; for use as tool in monitor protein, lipids, sugars and metabolite levels and their modifications in single living cells; immunodiagnostics |
| 01/06/2005 | US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease |
| 01/06/2005 | US20050003403 Multimeric protien for use in treatment and prevention of infections, nervous system, inflammatory, autoimmune and cell proliferative disorders |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003397 Peptide useful in immunomodulation |
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003387 Using tumor necrosis factor-related apoptosis-inducing ligand as a tool to identify modulators of programmed cell death for use in treatment of cell proliferative disorders |
| 01/06/2005 | US20050003384 Surface expression libraries of heteromeric receptors |
| 01/06/2005 | US20050003383 Linoleate isomerase |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003365 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo |
| 01/06/2005 | US20050003347 Protein fusion comprised of heavy chain with variable region, constant region, multivalent binding surface comprised of two conventional antigen binding sites and at least one non-conventional binding site formed by an interface between adjacently positioned heavy chain variable regions |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | US20050003329 Interactive dental restorative network |
| 01/06/2005 | US20050002959 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002945 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002942 Vitamin receptor binding drug delivery conjugates |
| 01/06/2005 | US20050002941 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases |
| 01/06/2005 | US20050002940 Cancerous disease modifying antibodies |
| 01/06/2005 | US20050002939 Treating ovarian cancer |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002937 Anti-IL-12 antibodies, compositions, methods and uses |
| 01/06/2005 | US20050002936 Methods and compositions useful for inhibition of angiogenesis |
| 01/06/2005 | US20050002934 Recombinant IL-9 antibodies and uses thereof |
| 01/06/2005 | US20050002932 Alleviation of symptoms associated with inflammatory disease states |
| 01/06/2005 | US20050002930 Methods of production and use of anti-integrin antibodies for the control of tissue granulation |
| 01/06/2005 | US20050002929 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/06/2005 | US20050002928 Treatment with anti-ErbB2 antibodies |
| 01/06/2005 | US20050002926 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 01/06/2005 | US20050002925 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them |
| 01/06/2005 | US20050002916 Cytokine-expressing cellular vaccine combinations |
| 01/06/2005 | CA2530388A1 Modified binding molecules comprising connecting peptides |
| 01/06/2005 | CA2530386A1 Antibodies against interleukin-22 and uses therefor |
| 01/06/2005 | CA2530020A1 Novel .beta.-actin and rps21 promoters and uses thereof |
| 01/06/2005 | CA2529945A1 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 01/06/2005 | CA2528961A1 Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 01/06/2005 | CA2528434A1 Combination therapy for b cell disorders |